Sign In
Buy MRK
$119.05
-1.73 (-1.43%)
At Close: Jun 12, 2026
Merck Eyes Revolution Medicines in a Potential $32 Billion Deal
11:14am, Friday, 09'th Jan 2026
Merck (MRK) is reportedly in talks to acquire Revolution Medicines (RVMD) for $28-$32 billion or more. This acquisition aims to strengthen MRK's oncology pipeli
First Look: GM's $7.1B EV Charge, Paramount's $30 WBD Bid
07:38am, Friday, 09'th Jan 2026
Stock News xAI under fire over Grok image edits: Elon Musk's xAI (private) restricted Grok's image generation/editing on X to paying users after the tool was us
Breakfast News: TSM Defies Bubble Fears
07:30am, Friday, 09'th Jan 2026
TSM enjoys revenue surge, Nvidia adds CMO for brand recognition, jobs report due, and more
Ferguson Wellman Capital Management Inc. Decreases Stock Holdings in Merck & Co., Inc. $MRK
05:34am, Friday, 09'th Jan 2026
Ferguson Wellman Capital Management Inc. reduced its position in shares of Merck and Co., Inc. (NYSE: MRK) by 1.0% in the third quarter, according to the company in its most recent disclosure with the
Merck In Talks To Buy Cancer Drug-Maker Revolution Medicines In A $28 To $32 Billion Deal — Stock Soars Overnight
01:52am, Friday, 09'th Jan 2026
Pharmaceuticals giant, Merck and Co. Inc. (NYSE: MRK), is reportedly in talks to acquire cancer drug-maker Revolution Medicines Inc. (NASDAQ: RVMD) in a deal potentially valued at between $28 and $32
Merck (MRK) Surpasses Market Returns: Some Facts Worth Knowing
06:51pm, Thursday, 08'th Jan 2026
Merck (MRK) concluded the recent trading session at $110.99, signifying a +2.2% move from its prior day's close.
Merck urges science-led US vaccine schedule after CDC trims childhood vaccine list
05:53pm, Thursday, 08'th Jan 2026
Merck on Thursday said any changes to the U.S. child and adolescent immunization schedule should rest on comprehensive data and guidance from vaccine experts, after federal health officials shifted se
Merck in talks to buy biotech Revolution Medicines, FT reports
03:56pm, Thursday, 08'th Jan 2026
Merck is in talks to buy cancer drug developer Revolution Medicines , the Financial Times reported on Thursday, citing people familiar with the matter.
Why Merck (MRK) is a Top Growth Stock for the Long-Term
10:45am, Thursday, 08'th Jan 2026
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Cramer's Stop Trading: Merck
10:31am, Thursday, 08'th Jan 2026
CNBC's Jim Cramer explains why he is keeping an eye on shares of Merck.
Merck: Fundamentals Amplified By A Momentum Breakout
08:00am, Thursday, 08'th Jan 2026
Merck has surged nearly 30% since my prior bullish call, reflecting strong share price momentum. MRK fundamentals are robust, underpinned by stellar financial performance and promising regulatory deve
Birch Hill Investment Advisors LLC Has $7.92 Million Stake in Merck & Co., Inc. $MRK
04:48am, Thursday, 08'th Jan 2026
Birch Hill Investment Advisors LLC reduced its position in shares of Merck and Co., Inc. (NYSE: MRK) by 11.5% during the undefined quarter, according to the company in its most recent 13F filing with
3 Drug Stocks to Buy at a Discount
04:00pm, Wednesday, 07'th Jan 2026
Eli Lilly's GLP-1 weight loss drug is leading investors to award it a massive P/E ratio of 53. That's far higher than the pharmaceutical sector's average P/E ratio of about 30.
The Big 3: XRT, MRK, CAT
01:00pm, Wednesday, 07'th Jan 2026
@Theotrade's Don Kaufman is bullish on the SPDR E&P Retail ETF (XRT) and Caterpillar (CAT) but tilts bearish on Merck (MRK). He explains his stance on today's Big 3 and offers example options trades f
Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation
12:36pm, Wednesday, 07'th Jan 2026
Merck could lose up to $630 million in Gardasil revenue this year now that the U.S. no longer recommends three doses of the HPV shot in the childhood vaccine schedule, according to Jefferies analysts.
